NFKB1 and non-small cell lung carcinoma: Under hypoxic conditions, the NF-κB pathway is activated, tumor proliferation and metastasis are enhanced, human NSCLC cells are less sensitive to cisplatin, and the efficacy of cisplatin chemotherapy is compromised.